Gossamer Bio Inc. has officially announced the final tender results for its exchange offer and consent solicitation regarding its outstanding convertible notes.

The company has confirmed that the relevant procedures have been completed as planned, achieving the anticipated level of participation. This move represents an important step for the company in optimizing its capital structure and managing debt maturities. The release of the final results provides the market with clear information, marking the end of a key phase of this financial operation.